Zobrazeno 1 - 10
of 754
pro vyhledávání: '"A Harlozinska"'
Autor:
Dorn, J. *, Magdolen, V., Gkazepis, A., Gerte, T., Harlozinska, A., Sedlaczek, P., Diamandis, E.P., Schuster, T., Harbeck, N., Kiechle, M., Schmitt, M.
Publikováno v:
In Annals of Oncology August 2011 22(8):1783-1790
Autor:
Gisterek, Iwona, Sedlaczek, Paweł, Kornafel, Jan, Harłoziñska-Szmyrka, Antonina, Łacko, Aleksandra
Publikováno v:
In American Journal of Otolaryngology--Head and Neck Medicine and Surgery 2007 28(2):73-77
Autor:
Schlade-Bartusiak, Kamila, Sasiadek, Maria M., Bar, Julia K., Urbschat, Steffi, Blin, Nikolaus, Montenarh, Mathias, Harłozińska-Szmyrka, Antonina
Publikováno v:
In Cancer Genetics and Cytogenetics 2006 164(1):10-15
Publikováno v:
In Reports of Practical Oncology & Radiotherapy 2005 10(2):17-23
Autor:
van Dalen, A., Favier, J., Burges, A., Hasholzner, U., de Bruijn, H.W.A., Dobler-Girdziunaite, D., Dombi, V.H., Fink, D., Giai, M., McGing, P., Harlozinska, A., Kainz, Ch., Markowska, J., Molina, R., Sturgeon, C., Bowman, A., Einarsson, R.
Publikováno v:
In Gynecologic Oncology December 2000 79(3):444-450
Publikováno v:
Scandinavian Journal of Haematology. 25:205-213
Acute myelogenous leukaemia cells (AML) and cells of chronic myelogenous leukaemia blast crisis (CGL-CB) were examined for the presence of receptors for Fc IgG fragment (FcR), receptors for the complement components (CR1 and CR2), and the surface imm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ab0d4ef55632dcc2657686a1d5be00f
https://doi.org/10.1111/j.1600-0609.1981.tb01390.x
https://doi.org/10.1111/j.1600-0609.1981.tb01390.x
Autor:
Ferreira, Mariana1,2 (AUTHOR) mariana.f.ferreira@ipoporto.min-saude.pt, Morais, Mariana1,2 (AUTHOR) mariana.gomes.morais@ipoporto.min-saude.pt, Medeiros, Rui1,2,3,4,5 (AUTHOR) ruimedei@ipoporto.min-saude.pt, Teixeira, Ana Luísa1 (AUTHOR) ana.luisa.teixeira@ipoporto.min-saude.pt
Publikováno v:
Pharmaceutics. Nov2024, Vol. 16 Issue 11, p1347. 23p.
Publikováno v:
Cancer. 95:1886-1893
BACKGROUND The serum markers CA125, tissue polypeptide specific antigen (TPS), and soluble interleukin-2 receptor alpha (sIL-2Rα) concentrations were determined in sera, cyst, and ascitic fluids from patients with malignant and benign ovarian neopla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d73102292d3a575e647b09ecc669008a
https://doi.org/10.1002/cncr.10917
https://doi.org/10.1002/cncr.10917
Autor:
Marian Kochman, Andrzej Ożyhar, Jan Rodriguez Parkitna, Ewa Wyrodek, Mathias Montenarh, A. Harlozinska, Julia K. Bar, Sabine Kartarius
Publikováno v:
Japanese Journal of Cancer Research : Gann
OvBH-1 cells from a patient with ovarian clear cell carcinoma were established and their biochemical status was analyzed. Cells grown at 37 degrees C exhibited normal cell cycle distribution, whereas the cells shifted to 31 degrees C were arrested in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75eef478cc12e5462503e7fb56766b00
http://europepmc.org/articles/PMC5927136
http://europepmc.org/articles/PMC5927136
Publikováno v:
Tumor Biology. 22:83-91
p53 alterations are considered as one of the most important factors responsible for drug resistance in ovarian carcinomas, although the relationship between p53 gene status and response to cisplatin-based chemotherapy in ovarian cancer patients remai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::706c88382cb72204154a2a9f0c98eb09
https://doi.org/10.1159/000050601
https://doi.org/10.1159/000050601